Skip to main content
EN
Caution:
At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
Patent Search
Details
see.ip - Details for VERWENDUNG VON RESLIZUMAB ZUR BEHANDLUNG VON MODERATEM BIS SCHWEREM EOSINOPHILEM ASTHMA
Details for 2015760590
Up to date per 17.06.2026
Actions
Copy link to European Patent
Download Registration Print
Details
Details for 2015760590
Title / Product Name
VERWENDUNG VON RESLIZUMAB ZUR BEHANDLUNG VON MODERATEM BIS SCHWEREM EOSINOPHILEM ASTHMA
Status
Granted/Registered
Protection Type
European Patent
(AT-) Application Number
2015760590
EP Publication Number
3191513
E-Number
1283810
Language
EN
PCT Number
US15047357
Publication Date
19.07.2017 A
24.06.2020 B1
Registration Date
24.06.2020
AT Publication Date
15.07.2020
Application Date
28.08.2015
Registration Number
-
Priorities
08.09.2014
US
201462047248 P
12.12.2014
US
201462091150 P
29.05.2015
US
201562168007 P
13.07.2015
US
201562191690 P
IPC
C07K 16/24 20060101AFI20160323BHEP
Maximum Duration of Protection
28.08.2035
Owner
Cephalon, Inc.
41 Moores Road P.O. Box 4011
Frazer, PA 19355
US
Representative
Representative
Häupl & Ellmeyer KG, Patentanwaltskanzlei
Mariahilfer Straße 50 (Eingang Kirchengasse 1)
1070 Wien
AT
Inventor
BRUSSELLE, Guy
Begonialaan 28
9840 De Pinte
BE
O'BRIEN, Christopher
110 Chinaberry Drive
Lafayette Hill, PA 19444
US
ZANGRILLI, James
1606 Chestnut Street Unit 2
Philadelphia, PA 19103
US
SHAH, Tushar
124 Hilcrest Road
Flemington, NJ 08022
US
Information about Fees
Click here to load the fees